Everest Health and Mains Lab target AED 1.5B+ in UAE claims fraud with AI screening system

Everest Health and Mains Lab will deploy artificial intelligence to detect fraud, waste, and claims leakage across the UAE healthcare system, the companies announced on 10 April 2026.

The collaboration targets a problem the World Health Organization estimates drains 5–10% of total health spending globally. In the UAE, where mandatory insurance covers more than 9.5 million residents and total insured healthcare expenditure exceeds AED 30 billion annually, that percentage represents AED 1.5 billion to AED 3 billion in recoverable losses each year.

What the partnership covers

The joint effort pairs Everest Health's claims management and payer-side operations with Mains Lab's AI and data analytics capabilities. The technology screens submissions in near real-time rather than relying on retrospective audits that typically catch irregularities months after payment. Specific targets include:

• Anomalous billing patterns and statistical outliers by provider
• Duplicate claims submitted across multiple payers
• Upcoding — billing for higher-cost procedures than those performed
• Phantom services with no corresponding patient record

Traditional claims review in the UAE relies on manual sampling, which catches an estimated 2–3% of problematic claims before payment. AI-based systems can screen 100% of submissions against historical patterns, provider benchmarks, and clinical logic rules. The gap between 3% and 100% screening is where the financial recovery concentrates.

Regulatory pressure is building

The partnership arrives as UAE regulators tighten oversight of claims integrity. The Dubai Health Authority (DHA) has expanded its claims audit programme over the past two years. The Department of Health Abu Dhabi (DOH) introduced updated billing compliance codes in late 2025, requiring providers to maintain auditable, AI-readable records. The Insurance Authority, now part of the Central Bank of the UAE, will impose stricter reporting obligations on fraud detection rates starting in Q3 2026.

For hospital CFOs, the implication is direct. Insurers that deploy better fraud detection will deny more inappropriate claims. Providers with weak billing compliance will see rejection rates climb. Facilities that have not invested in clean coding practices and internal audit systems face a widening gap between billed and collected revenue.

Regional precedent and market context

The UAE health insurance sector has consolidated rapidly. Daman, the Abu Dhabi national insurer, and a handful of large payers control the majority of premium volume. These dominant payers have the data scale to make AI-driven fraud detection effective. Smaller insurers and third-party administrators face a build-or-buy decision on analytics infrastructure, which is where partnerships like the Everest Health–Mains Lab arrangement fit.

Saudi Arabia's Council of Health Insurance launched its own AI claims review pilot in 2025 and flagged AED 1.1 billion in irregular claims in six months. The UAE market, with higher per-capita health spending and a more complex multi-payer structure, represents a larger but more fragmented opportunity.

COOs and IT heads at mid-size hospital groups should prepare now. As payer-side AI screening improves, tolerance for billing errors (whether intentional or not) will shrink. Providers that invest in claims accuracy on their end will preserve revenue. Those that do not will face an escalating cycle of denials, appeals, and delayed cash flow.